Expanding Product Portfolio Sonoma Pharmaceuticals has recently launched HOCl-based products for diaper rash and acne, demonstrating an active drive to diversify and expand its dermatological offerings. This presents opportunities to introduce additional specialized wound care and dermatological solutions to a broader range of healthcare providers and retail channels.

International Market Growth With its European headquarters in the Netherlands and recent efforts to distribute wound care products in Canada and the U.S., Sonoma is increasing its global footprint. This expansion opens up potential sales opportunities with international hospitals, clinics, and distributors within regions showing strong demand for innovative, infection-reducing solutions.

Strategic Partnerships The company's partnership with Medline Industries enhances its distribution reach, especially for wound care products across North America and Canada. Developing relationships with additional healthcare distributors and over-the-counter retail chains could further boost sales and market penetration.

Participation in Industry Events Active presence at prominent industry events such as MEDICA 2025 and the American Academy of Dermatology Meeting suggests a focus on brand visibility and new product promotion. Leveraging these opportunities for showcasing clinical efficacy and building relationships with key dermatology and wound care professionals can facilitate new sales channels.

Focus on Dermatological Solutions Sonoma’s emphasis on advanced tissue care and dermatological conditions, combined with its measurable impact on patient outcomes, positions it well for targeted outreach to dermatologists, wound care specialists, and healthcare facilities seeking innovative and effective infection control and healing products.